The full recommendations document has been accepted for publication in MJA. We are awaiting a publication date and will be sure to advise our Members when this information is available.
The purpose of The First IADPSG Summit on the Diagnosis of Gestational Diabetes in Early Pregnancy (the TOBOGM Summit) was to use the TOBOGM trial findings to scope the issues involved with early screening, to inform future discussions over possible approaches and criteria for diagnosing GDM in early pregnancy.
The TOBOGM Summit (Summit) was hosted by the IADPSG on 17th November 2022, in Sydney, Australia. Over 170 delegates from 21 countries attended, representing a range of health professionals/clinicians, academics, policy makers and consumers with lived experience. The report from this summit is available here for interested readers.
CLICK HERE to view the report now.